LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Immunology

Image: Outline of the Synthetic Cellular Advanced Signal Adapter (SCASA) system (Deichmann, M. et al., Nat Commun 16, 10306, 2025. DOI: 10.1038/s41467-025-65236-7)

Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy

A new testing platform reduces development time for new cancer immunotherapies from months to days. More...
06 Feb 2026
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

A blood-based marker can predict which lung cancer patients will benefit from a new immunotherapy drug. More...
22 Jan 2026
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

A whole-genome sequencing approach can guide PARP inhibitor cancer therapy. More...
16 Jan 2026
mage: Ultrasensitive circulating tumor DNA analysis enables early, noninvasive monitoring of immunotherapy response (Photo courtesy of Shutterstock)

Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response

Ultrasensitive liquid biopsy has shown promise in predicting immunotherapy responses across various cancers. More...
29 Dec 2025
Image: The GlioExoChip chip provides a quick and minimally invasive way to monitor glioblastoma treatment response (Photo courtesy of University of Michigan)

Diagnostic Chip Monitors Chemotherapy Effectiveness for Brain Cancer

A blood test could track chemotherapy effectiveness in glioblastoma after opening the blood–brain barrier. More...
26 Dec 2025
Image: A simple blood draw could help guide personalized treatment decisions after colon cancer surgery (Photo courtesy of 123RF)

Blood Test Could Identify Colon Cancer Patients to Benefit from NSAIDs

A blood test could identify which colon cancer patients stand to benefit from anti-inflammatory therapy after surgery. More...
25 Dec 2025
Image: The noninvasive cfDNA blood test can identify adverse events from immune checkpoint therapy in cancer patients (Photo courtesy of Elizabeth Cook)

Blood Test Could Detect Adverse Immunotherapy Effects

A blood test could help clinicians identify adverse events related to immunotherapy drugs. More...
22 Dec 2025
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT


The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.